Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta‐analysis

Triple therapies combining a double dose of proton pump inhibitor plus two antibiotics are the standard treatment for Helicobacter pylori infection. Some reports suggest that the use of half the dose of proton pump inhibitor is equally effective.

[1]  Y. Kinoshita,et al.  Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population , 2001, Journal of gastroenterology and hepatology.

[2]  J. Gisbert,et al.  Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pylori , 2000, Alimentary pharmacology & therapeutics.

[3]  C. Stedman,et al.  Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors , 2000, Alimentary pharmacology & therapeutics.

[4]  F. Périé,et al.  [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. , 2000, Gastroentérologie Clinique et Biologique.

[5]  J. Gisbert,et al.  [Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference]. , 2000, Medicina clinica.

[6]  Cooper,et al.  Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily , 2000, Alimentary pharmacology & therapeutics.

[7]  Burman,et al.  Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection , 1999, Alimentary pharmacology & therapeutics.

[8]  Mégraud,et al.  Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia , 1999, Alimentary pharmacology & therapeutics.

[9]  J. Gisbert,et al.  [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. , 1999, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[10]  R. Catanzaro,et al.  Comparative Treatment of Helicobacter pylori–Positive Duodenal Ulcer Using Pantoprazole at Low and High Doses Versus Omeprazole in Triple Therapy , 1999, Helicobacter.

[11]  Fuchs,et al.  Short‐term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori , 1999, Alimentary pharmacology & therapeutics.

[12]  R. Hunt,et al.  The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta‐analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole , 1999, Alimentary pharmacology & therapeutics.

[13]  R. Hunt,et al.  Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group. , 1999, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[14]  N. Sato,et al.  Efficacy of 1 week omeprazole or lansoprazole– amoxycillin–clarithromycin therapy for Helicobacter pylori infection in the Japanese population , 1999, Journal of gastroenterology and hepatology.

[15]  I. Hyodo,et al.  Evaluation of endoscopic injection sclerotherapy with and without simultaneous ligation for the treatment of esophageal varices , 1999, Journal of Gastroenterology.

[16]  T. Ogihara,et al.  Effectiveness of Omeprazole‐Amoxicillin‐Clarithromycin (OAC) Therapy for Helicobacter pylori Infection in a Japanese Population , 1998, Helicobacter.

[17]  Colombo,et al.  Comparison of omeprazole and lansoprazole in short‐term triple therapy for Helicobacter pylori infection , 1998, Alimentary pharmacology & therapeutics.

[18]  A. Sonnenberg,et al.  Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group. , 1998, Archives of internal medicine.

[19]  A. Pilotto,et al.  Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D. , 1998 .

[20]  J. Tijssen,et al.  Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. , 1997, Gastroenterology.

[21]  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. , 1997, Gut.

[22]  M. Blaser,et al.  The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. , 1994, Gastroenterology.

[23]  H. Satoh,et al.  Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells , 1993, Antimicrobial Agents and Chemotherapy.

[24]  H. Satoh,et al.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori , 1991, Antimicrobial Agents and Chemotherapy.

[25]  T C Chalmers,et al.  A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.

[26]  Y. Takei,et al.  Efficacy of Reduced Dosage of Rabeprazole in PPI/AC Therapy for Helicobacter pylori Infection , 2004, Digestive Diseases and Sciences.

[27]  N. Chiba,et al.  Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[28]  J. Gisbert,et al.  Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la II Conferencia Española de Consenso , 2000 .

[29]  G. Tytgat,et al.  Regular review: treatment of Helicobacter pylori infection. , 2000, BMJ.

[30]  K. Lau,et al.  A randomised controlled study comparing the efficacy of once-daily triple therapy with twice-daily triple therapy in the eradication of Helicobacter pylori , 1999 .

[31]  J. Toyota,et al.  Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy. , 1999, Journal of gastroenterology.

[32]  A. Goddard,et al.  Bioavailability of antimicrobials after oral and parenteral administration , 1998 .

[33]  D. Forman,et al.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. , 1997, Gut.

[34]  G. Tytgat.  Aspects of anti- Helicobacter pylori eradication therapy , 1996 .

[35]  R. Mark.  [Comparative treatment]. , 1955, Wiener medizinische Wochenschrift.